269 related articles for article (PubMed ID: 31828732)
1. β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers.
Nilsson MB; Le X; Heymach JV
J Neuroimmune Pharmacol; 2020 Mar; 15(1):27-36. PubMed ID: 31828732
[TBL] [Abstract][Full Text] [Related]
2. Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.
Nilsson MB; Sun H; Diao L; Tong P; Liu D; Li L; Fan Y; Poteete A; Lim SO; Howells K; Haddad V; Gomez D; Tran H; Pena GA; Sequist LV; Yang JC; Wang J; Kim ES; Herbst R; Lee JJ; Hong WK; Wistuba I; Hung MC; Sood AK; Heymach JV
Sci Transl Med; 2017 Nov; 9(415):. PubMed ID: 29118262
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of β-blockers on human colorectal cancer cells.
Coelho M; Moz M; Correia G; Teixeira A; Medeiros R; Ribeiro L
Oncol Rep; 2015 May; 33(5):2513-20. PubMed ID: 25812650
[TBL] [Abstract][Full Text] [Related]
4. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.
Coelho M; Soares-Silva C; Brandão D; Marino F; Cosentino M; Ribeiro L
J Cancer Res Clin Oncol; 2017 Feb; 143(2):275-291. PubMed ID: 27709364
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways: beta-adrenergic signaling in cancer.
Cole SW; Sood AK
Clin Cancer Res; 2012 Mar; 18(5):1201-6. PubMed ID: 22186256
[TBL] [Abstract][Full Text] [Related]
6. Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: implications for anti-cancer drug targets.
Al-Wadei HA; Ullah MF; Al-Wadei MH
Pharmacol Res; 2012 Jul; 66(1):33-40. PubMed ID: 22487140
[TBL] [Abstract][Full Text] [Related]
7. The role of adrenergic signaling in breast cancer biology.
Obeid EI; Conzen SD
Cancer Biomark; 2013; 13(3):161-9. PubMed ID: 23912488
[TBL] [Abstract][Full Text] [Related]
8. The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer.
Yang EV; Eubank TD
Cancer Biomark; 2013; 13(3):155-60. PubMed ID: 23912487
[TBL] [Abstract][Full Text] [Related]
9. Circulating epinephrine is not required for chronic stress to enhance metastasis.
Walker AK; Martelli D; Ziegler AI; Lambert GW; Phillips SE; Hill SJ; McAllen RM; Sloan EK
Psychoneuroendocrinology; 2019 Jan; 99():191-195. PubMed ID: 30253326
[TBL] [Abstract][Full Text] [Related]
10. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC
Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway.
Huang XY; Wang HC; Yuan Z; Huang J; Zheng Q
Hepatogastroenterology; 2012 May; 59(115):889-93. PubMed ID: 22020907
[TBL] [Abstract][Full Text] [Related]
12. Positive inotropic stimulation.
Leone M; Albanèse J; Martin C
Curr Opin Crit Care; 2002 Oct; 8(5):395-403. PubMed ID: 12357106
[TBL] [Abstract][Full Text] [Related]
13. Effects of β-adrenergic receptor drugs on embryonic ventricular cell proliferation and differentiation and their impact on donor cell transplantation.
Feridooni T; Hotchkiss A; Baguma-Nibasheka M; Zhang F; Allen B; Chinni S; Pasumarthi KBS
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H919-H931. PubMed ID: 28283550
[TBL] [Abstract][Full Text] [Related]
14. Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation.
Min HY; Boo HJ; Lee HJ; Jang HJ; Yun HJ; Hwang SJ; Smith JK; Lee HJ; Lee HY
Oncotarget; 2016 Oct; 7(43):70936-70947. PubMed ID: 27708216
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro.
Zhang J; Deng YT; Liu J; Wang YQ; Yi TW; Huang BY; He SS; Zheng B; Jiang Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):423-35. PubMed ID: 26358081
[TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
Lobb RJ; van Amerongen R; Wiegmans A; Ham S; Larsen JE; Möller A
Int J Cancer; 2017 Aug; 141(3):614-620. PubMed ID: 28445609
[TBL] [Abstract][Full Text] [Related]
17. The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference.
He RH; He YJ; Tang YJ; Zhou HH; McLeod HL; Liu J
Pharmacogenomics; 2016; 17(1):74-9. PubMed ID: 26652861
[TBL] [Abstract][Full Text] [Related]
18. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A
J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
[TBL] [Abstract][Full Text] [Related]
19. Beta-blockers: Historical Perspective and Mechanisms of Action.
Oliver E; Mayor F; D'Ocon P
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):853-862. PubMed ID: 31178382
[TBL] [Abstract][Full Text] [Related]
20. Three Generations of β-blockers: History, Class Differences and Clinical Applicability.
do Vale GT; Ceron CS; Gonzaga NA; Simplicio JA; Padovan JC
Curr Hypertens Rev; 2019; 15(1):22-31. PubMed ID: 30227820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
